SLIT2 was mutated in 3 smoker samples and its lower expression is known to promote metastasis by activation of srGAP-Cdc42 pathway and is significantly correlated with poor overall survival and disease-free survival in ESCC patients (75). Here, SLIT2 is linked to esophageal squamous cell carcinoma.